These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7295998)

  • 41. Clinical implications of factor XII deficiency.
    McDonough RJ; Nelson CL
    Oral Surg Oral Med Oral Pathol; 1989 Sep; 68(3):264-6. PubMed ID: 2771371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome.
    Saito H; Goodnough LT; Makker SP; Kallen RJ
    Am J Med; 1981 Mar; 70(3):531-4. PubMed ID: 7211894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary mortality and living standard. II. Coffee, tea, cocoa, alcohol and tobacco.
    Brummer P
    Acta Med Scand; 1969; 186(1-2):61-3. PubMed ID: 5807646
    [No Abstract]   [Full Text] [Related]  

  • 45. Functional characterization of an abnormal factor XII molecule (F XII Bern).
    Wuillemin WA; Huber I; Furlan M; Lämmle B
    Blood; 1991 Aug; 78(4):997-1004. PubMed ID: 1868256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaphylactic release of a prekallikrein activator from human lung in vitro.
    Meier HL; Kaplan AP; Lichtenstein LM; Revak S; Cochrane CG; Newball HH
    J Clin Invest; 1983 Aug; 72(2):574-81. PubMed ID: 6192147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The first cases of Fitzgerald factor deficiency in the Orient: three cases in one family.
    Hayashi H; Koya H; Kuroda M; Kitazima K; Kimura I; Katori M; Oh-ishi S
    Acta Haematol; 1980; 63(2):107-13. PubMed ID: 6768213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII).
    Saito H; Ishihara T; Suzuki H; Watanabe T
    Blood; 1985 May; 65(5):1263-8. PubMed ID: 3922451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 53. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of rabbit antisera in the preparation of factor-XII-free platelet-rich and platelet-poor plasma.
    Muntz RH; Castaldi PA
    Haemostasis; 1977; 6(1):35-40. PubMed ID: 858558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency.
    Bouma BN; Kerbiriou DM; Baker J; Griffin JH
    J Clin Invest; 1986 Jul; 78(1):170-6. PubMed ID: 3487556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():657-9. PubMed ID: 15658416
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of antigen structure in the regulation of IgE isotype expression.
    Francus T; Siskind GW; Becker CG
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3430-4. PubMed ID: 6574492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotes.
    Girolami A; Gavasso S; Pacquola E; Cabrio L; Lombardi AM; Girolami B
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):335-8. PubMed ID: 16015420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.